Studies show Mounjaro may lead to more average weight loss than Ozempic, but side effects and results can vary from person to person
BlueWater Wellness Center offers FDA-approved GLP-1 medical weight loss with semaglutide and tirzepatidethe same medications delivering average 15-20% body weight loss in clinical trials
FIGURE 3 2.4 GPX4 Glutathione peroxidase 4 (GPX4) is a membrane-associated phospholipid hydroperoxidase and the only enzyme in the GPX family that directly reduces and destroys lipid hydroperoxides, GPX4 is characterized early and characterizes as the lipid peroxidation inhibitory protein PIP, mainly due to its unique ability ( 2 O 2 and small molecule hydroperoxides, it is also capable of reducing complex lipid compounds such as phospholipids, cholesterol and cholesterol lipid hydroperoxides
Tirzepatide Considerations There is a lot of noise around GLP-1 medications right now
However, improved energy and metabolic function can support weight management efforts
Ozempic Mounjaro and Ozempic are weekly injections approved by the FDA for Type 2 diabetes
